These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 32459969)
1. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer. Zhou L; Hou B; Wang D; Sun F; Song R; Shao Q; Wang H; Yu H; Li Y Nano Lett; 2020 Jun; 20(6):4393-4402. PubMed ID: 32459969 [TBL] [Abstract][Full Text] [Related]
2. Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy. Su T; Cheng F; Qi J; Zhang Y; Zhou S; Mei L; Fu S; Zhang F; Lin S; Zhu G Adv Sci (Weinh); 2022 Aug; 9(23):e2201895. PubMed ID: 35712773 [TBL] [Abstract][Full Text] [Related]
3. Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy. Liu Z; Liu B; Feng Y; Zhao L; Wang Q; He H; Yin T; Zhang Y; Yang L; Gou J; Tang X ACS Nano; 2024 Jun; 18(24):15557-15575. PubMed ID: 38837909 [TBL] [Abstract][Full Text] [Related]
4. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739 [TBL] [Abstract][Full Text] [Related]
5. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment. Wang Z; Miao F; Gu L; Zhang R; Ma Y; Li Y; Zheng J; Lin Z; Gao Y; Huang L; Shen Y; Wu T; Luo F; Li W ACS Nano; 2024 Sep; 18(35):24219-24235. PubMed ID: 39172516 [TBL] [Abstract][Full Text] [Related]
6. Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma. Chu Y; Qian L; Ke Y; Feng X; Chen X; Liu F; Yu L; Zhang L; Tao Y; Xu R; Wei J; Liu B; Liu Q J Nanobiotechnology; 2022 Apr; 20(1):190. PubMed ID: 35418151 [TBL] [Abstract][Full Text] [Related]
7. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response. Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929 [TBL] [Abstract][Full Text] [Related]
8. Biomimetic Nanovaccines Potentiating Dendritic Cell Internalization via CXCR4-Mediated Macropinocytosis. Yang C; Zhang F; Chen F; Chang Z; Zhao Y; Shao D; Sun W; Dong WF; Wang Z Adv Healthc Mater; 2023 Feb; 12(5):e2202064. PubMed ID: 36416257 [TBL] [Abstract][Full Text] [Related]
9. Self-Adjuvanted Molecular Activator (SeaMac) Nanovaccines Promote Cancer Immunotherapy. Luo Z; He T; Liu P; Yi Z; Zhu S; Liang X; Kang E; Gong C; Liu X Adv Healthc Mater; 2021 Apr; 10(7):e2002080. PubMed ID: 33336537 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
11. Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy. Li T; Chen G; Lin L; Li B; Wang X; Chen Y; Huang W; Cai M; Xiao Z; Shuai X; Zhu K Biomaterials; 2024 Sep; 309():122626. PubMed ID: 38795524 [TBL] [Abstract][Full Text] [Related]
12. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer. Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897 [TBL] [Abstract][Full Text] [Related]
14. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy. Liu J; Cui Y; Cabral H; Tong A; Yue Q; Zhao L; Sun X; Mi P ACS Nano; 2024 Sep; 18(37):25826-25840. PubMed ID: 39196858 [TBL] [Abstract][Full Text] [Related]
15. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy. Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785 [TBL] [Abstract][Full Text] [Related]
16. Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine. Yang C; He Y; Chen F; Zhang F; Shao D; Wang Z Small; 2023 Apr; 19(14):e2207029. PubMed ID: 36703529 [TBL] [Abstract][Full Text] [Related]
17. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy. Jiang X; Wang J; Zheng X; Liu Z; Zhang X; Li Y; Wilhelm J; Cao J; Huang G; Zhang J; Sumer B; Lea J; Lu Z; Gao J; Luo M J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35623658 [TBL] [Abstract][Full Text] [Related]
18. Minimalist Nanovaccine with Optimized Amphiphilic Copolymers for Cancer Immunotherapy. Niu L; Miao Y; Cao Z; Wei T; Zhu J; Li M; Bai B; Chen L; Liu N; Pan F; Zhu J; Wang C; Yang Y; Chen Q ACS Nano; 2024 Jan; 18(4):3349-3361. PubMed ID: 38230639 [TBL] [Abstract][Full Text] [Related]
19. Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy. Zhao H; Xu J; Li Y; Guan X; Han X; Xu Y; Zhou H; Peng R; Wang J; Liu Z ACS Nano; 2019 Nov; 13(11):13127-13135. PubMed ID: 31710460 [TBL] [Abstract][Full Text] [Related]
20. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines. Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]